---
title: "CICC Sticks to Its Buy Rating for CIMC Enric Holdings (CIMEF)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281132485.md"
description: "CICC analyst maintained a Buy rating on CIMC Enric Holdings yesterday and set a price target of HK$12.00.End of Quarter Sale - 50% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Currently, the analyst consensus on CIMC Enric Holdings is a Strong Buy with an average price target of HK$13.56."
datetime: "2026-03-31T06:06:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281132485.md)
  - [en](https://longbridge.com/en/news/281132485.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281132485.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/281132485.md) | [繁體中文](https://longbridge.com/zh-HK/news/281132485.md)


# CICC Sticks to Its Buy Rating for CIMC Enric Holdings (CIMEF)

CICC analyst maintained a Buy rating on CIMC Enric Holdings yesterday and set a price target of HK$12.00.

### End of Quarter Sale - 50% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Currently, the analyst consensus on CIMC Enric Holdings is a Strong Buy with an average price target of HK$13.56.

### Related Stocks

- [CIMC ENRIC (03899.HK)](https://longbridge.com/en/quote/03899.HK.md)

## Related News & Research

- [CIMC Enric to Raise HK$774 Million via Discounted Share Placement](https://longbridge.com/en/news/273004923.md)
- [Longfor Group Holdings (LNGPF) Gets a Buy from CICC](https://longbridge.com/en/news/280899756.md)
- [CSC Financial Sticks to Their Buy Rating for Longfor Group Holdings (LNGPF)](https://longbridge.com/en/news/280898279.md)
- [CICC Sticks to Its Buy Rating for Wasion Holdings Limited (3393)](https://longbridge.com/en/news/280867578.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/en/news/281325910.md)